News
September 18, 2023

Executive director of Health Data Standards at Regenstrief Institute elected as a director on HL7® International Board of Directors

Marjorie Rallins

Marjorie Rallins, DPM, M.S., has been elected to the Health Level Seven® (HL7®) International Board of Directors during the 37th Annual Plenary, Working Group Meeting and HL7® FHIR® Connectathon, in Phoenix, Arizona.

As a director on the HL7® Board of Directors, Dr. Rallins will provide insight for the continued development and maintenance of the HL7® strategic plan. She will also help in creating advisory groups and councils to fulfill liaison duties with partner organizations and ratify recommended appointments for representatives to those partners. Dr. Rallins will serve on the board from January 1, 2024, through December 31, 2025.

A nationally recognized leader in clinical standards and informatics, Dr. Rallins began her duties with Regenstrief Institute in January of 2021. She guides the Health Data Standards unit in stewarding LOINC® and UCUM (Unified Codes for Units of Measure) and serving as the focal point for data standards initiatives and policies across Regenstrief.  She previously served as vice president and chief scientific officer of the PCPI® Foundation in Chicago as well as director of clinical informatics and business strategies for the American Medical Association. Her proven unique experience in clinical data standards, business development and thought leadership positions Regenstrief to continue facilitating healthcare interoperability across a broad spectrum of partners.

Regenstrief and HL7® have had an agreement to create a complementary process to develop and extend comprehensive standards in the healthcare industry since 2011. HL7® is a critical stakeholder and collaborator with Regenstrief and the data standards community.

At the HL7® work group meetings, attendees have opportunities to meet face to face to work on the standards as well as network with industry leaders from around the world. The international meeting also provides attendees with an educational resource for the healthcare IT community.

About Regenstrief Institute
Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform clinical practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

About Health Level Seven® International (HL7®)
HL7® is an ANSI-accredited, not-for-profit standards developing organization with the mission of empowering global health interoperability. With affiliates in over 30 countries, HL7’s global membership envisions a world in which everyone can securely access and use the right data when and where they need it. Widely implemented by vendor and healthcare systems, and required by governing bodies around the world, HL7 standards deliver solutions for health information technology, including HL7® Fast Healthcare Interoperability Resources (FHIR®), Version 2 (V2) and Clinical Document Architecture (CDA®).

Related News

Brian Dixon, PhD, MPA, and Shaun Grannis, MD, MS

Large, real world, multistate study finds COVID-19 vaccine cuts risk of disease in half when administered during pregnancy

A large multistate study, conducted by the Centers for Disease Control and Prevention’s (CDC’s) VISION Network, has found that

CMS launches new mandatory kidney transplant payment model

Regenstrief Institute research cited in new federal rule A new final rule issued by the Centers for Medicare and